Q1 2024 Holdings
Filed 2024-05-15 | 59 holdings | $4.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $667.6M | 11,357,425 | 16.9% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $286.9M | 11,584,280 | 7.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $277.7M | 6,726,491 | 7.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $248.5M | 1,919,835 | 6.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $194.5M | 4,155,375 | 4.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $185.4M | 5,756,268 | 4.7% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $169.4M | 7,521,024 | 4.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $141.4M | 13,437,473 | 3.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $123.9M | 5,806,871 | 3.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $122.1M | 1,013,952 | 3.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $118.0M | 5,330,416 | 3.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $110.8M | 5,991,479 | 2.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $105.8M | 13,330,736 | 2.7% |
| Immunome Inc(IMNM) | COM | 45257U108 | $95.7M | 3,879,415 | 2.4% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $94.7M | 1,389,276 | 2.4% |
| Mersana Therapeutics Inc | COM | 59045L106 | $86.8M | 19,364,688 | 2.2% |
| Morphic Hldg Inc | COM | 61775R105 | $83.9M | 2,384,384 | 2.1% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $69.9M | 19,209,643 | 1.8% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $64.7M | 1,271,342 | 1.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $63.5M | 5,618,779 | 1.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $47.0M | 3,418,068 | 1.2% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $43.3M | 27,404,070 | 1.1% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $39.7M | 5,000,000 | 1.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $36.5M | 3,917,546 | 0.9% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $30.0M | 3,182,444 | 0.8% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $28.5M | 2,071,450 | 0.7% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $27.3M | 650,000 | 0.7% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $27.3M | 1,999,249 | 0.7% |
| Lenz Therapeutics Inc(LENZ) | COM ADDED | 52635N103 | $27.2M | 1,219,774 | 0.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $24.8M | 6,145,861 | 0.6% |
| Alector Inc(ALEC) | COM | 014442107 | $24.4M | 4,056,548 | 0.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $22.8M | 1,250,385 | 0.6% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $21.6M | 2,000,000 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $20.8M | 900,000 | 0.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $20.5M | 300,000 | 0.5% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $20.0M | 75,000 | 0.5% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $19.3M | 757,576 | 0.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $18.7M | 6,117,400 | 0.5% |
| Verve Therapeutics Inc | COM | 92539P101 | $16.6M | 1,250,000 | 0.4% |
| Kura Oncology Inc(KURA)Call | COM | 50127T109 | $14.9M | 700,000 | 0.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $12.4M | 187,500 | 0.3% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $12.1M | 427,039 | 0.3% |
| Kyverna Therapeutics Inc(KYTX) | COM ADDED | 501976104 | $11.2M | 450,000 | 0.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $10.9M | 9,195,404 | 0.3% |
| Allovir Inc | COM | 019818103 | $8.5M | 11,294,585 | 0.2% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $8.5M | 1,613,600 | 0.2% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $8.3M | 2,046,867 | 0.2% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $7.1M | 10,167,043 | 0.2% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $6.6M | 2,884,357 | 0.2% |
| Aligos Therapeutics Inc | COM | 01626L105 | $6.3M | 6,389,468 | 0.2% |